Recurrent lobar intracerebral hemorrhage in Tangier disease

Wuwei Feng1, Evgeny Sidorov, Kara Smith

  • 1Department of Neurology, Division of Cerebrovascular Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.

Insights

Familial α-lipoprotein deficiency (Tangier disease) patients may experience intracerebral hemorrhages due to probable cerebral amyloid angiopathy. This suggests a link between ABCA1 gene mutations and brain apolipoprotein-E, impacting cerebral amyloid angiopathy development.

Area of Science:

  • Neuroscience
  • Genetics
  • Cardiovascular Medicine

Background:

  • Familial α-lipoprotein deficiency, also known as Tangier disease, is a rare genetic disorder characterized by severe deficiency or absence of high-density lipoprotein (HDL).
  • Cerebral amyloid angiopathy (CAA) is a common cause of non-traumatic intracerebral hemorrhage, particularly in the elderly, associated with the deposition of amyloid-beta protein in cerebral vessel walls.

Observation:

  • A patient with Tangier disease presented with recurrent lobar intracerebral hemorrhages.
  • Magnetic resonance imaging (MRI) revealed accumulating microbleeds, indicative of probable cerebral amyloid angiopathy.

Findings:

  • The study highlights a potential connection between mutations in the adenotriphosphate-binding cassette A1 (ABCA1) transporter gene, causative for Tangier disease, and apolipoprotein-E (ApoE) expression within the brain.
  • This association suggests a novel pathway linking Tangier disease pathophysiology to the development of cerebral amyloid angiopathy.

Implications:

  • The findings suggest that ABCA1 transporter dysfunction may play a role in the pathogenesis of cerebral amyloid angiopathy.
  • Further research into the ABCA1 transporter's role in cerebral amyloid angiopathy could lead to new therapeutic strategies for patients with Tangier disease and those at risk for cerebral hemorrhages.

Related Concept Videos

Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...